Date published: 2025-11-26

1-800-457-3801

SCBT Portrait Logo
Seach Input

S-100A5 Inhibitors

S-100A5 inhibitors represent a diverse class of chemical compounds that are specifically designed to modulate the activity of the S-100A5 protein. S-100A5 is a member of the S-100 protein family, a group of small, calcium-binding proteins known for their involvement in various cellular processes. S-100A5, in particular, plays a role in calcium signaling and has been associated with several physiological functions, including neuronal development, cell proliferation, and apoptosis. Consequently, the development of inhibitors targeting S-100A5 is of considerable interest in elucidating its precise functions within cellular pathways.

These inhibitors exert their effects primarily by interfering with the activity of S-100A5 through different mechanisms. Some inhibitors, such as KN-93, act by blocking the calcium/calmodulin-dependent protein kinase II (CaMKII), which phosphorylates and activates S-100A5. Others, like SB-203580, indirectly inhibit S-100A5 by targeting upstream signaling molecules like p38 MAP kinase, blocking the phosphorylation of S-100A5. Additionally, compounds like A-485, which are histone deacetylase (HDAC) inhibitors, may indirectly influence S-100A5 by modulating the acetylation status of proteins that interact with S-100A5. This chemical class showcases the versatility of approaches employed to regulate S-100A5's functions, highlighting the complex network of pathways associated with this protein. Further research into the specific mechanisms and consequences of S-100A5 inhibition could provide valuable insights into its role in cellular biology and applications.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

KN-93

139298-40-1sc-202199
1 mg
$178.00
25
(1)

KN-93 inhibits S-100A5 by blocking the calcium/calmodulin-dependent protein kinase II (CaMKII), which regulates S-100A5 phosphorylation and activity.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

SB-203580 is a p38 MAP kinase inhibitor that indirectly inhibits S-100A5 by blocking its phosphorylation via p38 MAP kinase.

A-485

1889279-16-6sc-507493
5 mg
$275.00
(0)

A-485 is a histone deacetylase (HDAC) inhibitor that affects S-100A5 by modulating the acetylation status of its interacting proteins.

BAPTA/AM

126150-97-8sc-202488
sc-202488A
25 mg
100 mg
$138.00
$449.00
61
(2)

BAPTA-AM chelates intracellular calcium ions, indirectly inhibiting S-100A5 by disrupting its calcium-dependent functions.

A-803467

944261-79-4sc-201068
sc-201068B
sc-201068A
10 mg
25 mg
50 mg
$87.00
$184.00
$342.00
1
(1)

A-803467 is a selective Nav1.8 sodium channel blocker, which indirectly influences S-100A5 through neuronal signaling pathways.

GW3965

405911-09-3sc-490151
sc-490151A
sc-490151B
10 mg
50 mg
1 g
$260.00
$872.00
$1637.00
(0)

GW3965 is a liver X receptor (LXR) agonist that may affect S-100A5 expression through LXR-mediated transcriptional regulation.

TBB

17374-26-4sc-202830
sc-202830A
sc-202830C
sc-202830B
sc-202830D
10 mg
25 mg
50 mg
100 mg
250 mg
$240.00
$363.00
$445.00
$760.00
$1781.00
17
(1)

TBB is a casein kinase 2 (CK2) inhibitor, potentially inhibiting S-100A5 phosphorylation by CK2, thereby affecting its activity.

SB 265610

211096-49-0sc-361341
sc-361341A
1 mg
10 mg
$81.00
$209.00
(0)

SB-265610 is a CXCR2 antagonist, which indirectly influences S-100A5 expression through chemokine receptor signaling pathways.

MK-2206 dihydrochloride

1032350-13-2sc-364537
sc-364537A
5 mg
10 mg
$178.00
$325.00
67
(1)

MK-2206 is an Akt inhibitor that may impact S-100A5 activity through the PI3K/Akt signaling pathway.

CGP 57380

522629-08-9sc-202993
5 mg
$172.00
6
(1)

CGP-57380 inhibits p21-activated kinase 4 (PAK4), which indirectly affects S-100A5 through PAK4-mediated signaling pathways.